Silibinin: a thorny therapeutic for EGF-R expressing tumors?
Hannay
Jonathan A F
JA
The University of Texas, M.D. Anderson Cancer Center; Houston, Texas USA.
Yu
Dihua
D
D000818:Animals; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D002470:Cell Survival / Q000187:drug effects; D066246:ErbB Receptors / Q000378:metabolism*; D005910:Glioma / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D020944:Silybum marianum; D010766:Phosphorylation / Q000187:drug effects; D051381:Rats; D015398:Signal Transduction / Q000187:drug effects*; D000077385:Silybin; D012838:Silymarin / Q000627:therapeutic use*
D012838:Silymarin; D000077385:Silybin; D066246:ErbB Receptors